rs201610096
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_022124.6(CDH23):c.3895G>A(p.Val1299Ile) variant causes a missense change. The variant allele was found at a frequency of 0.00047 in 1,613,972 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. V1299V) has been classified as Likely benign.
Frequency
Consequence
NM_022124.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CDH23 | NM_022124.6 | c.3895G>A | p.Val1299Ile | missense_variant | 32/70 | ENST00000224721.12 | |
CDH23 | NM_001171930.2 | c.3895G>A | p.Val1299Ile | missense_variant | 32/32 | ||
C10orf105 | NM_001168390.2 | c.-6+5562C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CDH23 | ENST00000224721.12 | c.3895G>A | p.Val1299Ile | missense_variant | 32/70 | 5 | NM_022124.6 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.000289 AC: 44AN: 152212Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000197 AC: 49AN: 248980Hom.: 0 AF XY: 0.000222 AC XY: 30AN XY: 135120
GnomAD4 exome AF: 0.000488 AC: 714AN: 1461642Hom.: 0 Cov.: 31 AF XY: 0.000428 AC XY: 311AN XY: 727094
GnomAD4 genome ? AF: 0.000289 AC: 44AN: 152330Hom.: 0 Cov.: 32 AF XY: 0.000295 AC XY: 22AN XY: 74496
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Dec 28, 2022 | Reported as likely benign in published literature due to lack of segregation with the phenotype but additional evidence is not available (Le Quesne et al., 2012; He et al., 2017); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 22135276, 28900111) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Sep 13, 2022 | This sequence change replaces valine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 1299 of the CDH23 protein (p.Val1299Ile). This variant is present in population databases (rs201610096, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with CDH23-related conditions. ClinVar contains an entry for this variant (Variation ID: 45932). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CDH23 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Usher syndrome type 1D Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 28, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Autosomal recessive nonsyndromic hearing loss 12 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 28, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jul 05, 2013 | Val1299Ile in Exon 32A of CDH23: This variant is not expected to have clinical s ignificance because it has been identified in 0.1% (1/593) of European chromosom es by the ClinSeq project and in 0.06% (5/8414) of European American chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/; dbSNP rs201610096), is reported as likely benign (Le Quesne Stabej 2012), and the val ine (Val) residue at position 1299 is not conserved in lower species with frog h aving an isoleucine (Ile). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at